Timothy A. Wicks
Known title: DirectorCIK: 0001339919
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
MiniMed Set for Medtronic Split-Off, Analysts Set New Targets. Medtronic has finalized the exchange ratio for the MiniMed split-off, a key corporate event for the stock. Meanwhile, Mizuho raised its price target to $28, while Barclays initiated coverage with a lower target of $22. Recent studies also highlighted that responding to MiniMed's diabetes alerts is linked to better glucose outcomes.
Transaction History
| BTSG | ▲ Buy | Grant | 4,983 | $0 | 5/5/2026 | View on chart |
| MMED | ▲ Buy | Grant | 13,889 | $0 | 3/9/2026 | View on chart |
| BTSG | ▲ Buy | Grant | 11,912 | $0 | 5/5/2025 | View on chart |
| BTSG | ▼ Sell | Tax Withholding | 7,044 | $147K | 5/3/2025 | View on chart |
| BTSG | ▲ Buy | Grant | 15,653 | $0 | 5/3/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
BrightSpring Health Shares Rise Ahead of Q3 Earnings and AI Rollout
BrightSpring Health (BTSG) shares climbed today as the company announced it will report third‑quarter 2026 results on Oct. 30 and outlined plans to expand specialty pharmacy, pursue M&A and deploy AI across operations. The move follows a comparison with Option Care Health that highlighted BrightSpring’s broader service mix. Investors are watching whether the AI initiative will lift margins and support the company’s growth strategy.
BrightSpring Health Shares Rise Ahead of Q3 Earnings and AI Rollout. BrightSpring Health (BTSG) shares climbed today as the company announced it will report third‑quarter 2026 results on Oct. 30 and outlined plans to expand specialty pharmacy, pursue M&A and deploy AI across operations. The move follows a comparison with Option Care Health that highlighted BrightSpring’s broader service mix. Investors are watching whether the AI initiative will lift margins and support the company’s growth strategy.